Hisafumi Okabe

400 total citations
11 papers, 237 citations indexed

About

Hisafumi Okabe is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Hisafumi Okabe has authored 11 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Immunology. Recurrent topics in Hisafumi Okabe's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (2 papers) and Platelet Disorders and Treatments (2 papers). Hisafumi Okabe is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (2 papers) and Platelet Disorders and Treatments (2 papers). Hisafumi Okabe collaborates with scholars based in Japan, Switzerland and Australia. Hisafumi Okabe's co-authors include Tetsuro Kubota, Koichiro Kumai, Masaki Kitajima, Teiji Takechi, Yoshiki Ishikawa, Tatsuo Teramoto, Masakazu Fukushima, Masahiko Watanabe, Kazuhiro Suganuma and Masahiko Watanabe and has published in prestigious journals such as Blood, Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Hisafumi Okabe

10 papers receiving 233 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hisafumi Okabe Japan	6	125	98	57	29	23	11	237
Mehrad Tavallai United States	11	129 1.0×	213 2.2×	59 1.0×	27 0.9×	14 0.6×	15	376
Emily Anderson United States	8	104 0.8×	361 3.7×	84 1.5×	43 1.5×	15 0.7×	15	532
Maria Dan United States	10	94 0.8×	121 1.2×	30 0.5×	62 2.1×	7 0.3×	22	319
Y Uzuka Japan	9	130 1.0×	141 1.4×	17 0.3×	11 0.4×	14 0.6×	37	320
Ajay Abraham United States	10	86 0.7×	247 2.5×	23 0.4×	25 0.9×	9 0.4×	30	389
Hiroaki Ihara Japan	11	63 0.5×	65 0.7×	185 3.2×	13 0.4×	22 1.0×	31	307
Tingbo Liu China	12	86 0.7×	134 1.4×	15 0.3×	51 1.8×	19 0.8×	49	306
J. Gardiner United Kingdom	5	103 0.8×	57 0.6×	34 0.6×	30 1.0×	14 0.6×	11	212
Shunji Kamazawa Japan	9	177 1.4×	185 1.9×	26 0.5×	41 1.4×	36 1.6×	13	371
A Terranova Italy	6	47 0.4×	88 0.9×	21 0.4×	25 0.9×	33 1.4×	11	323

Countries citing papers authored by Hisafumi Okabe

Since Specialization

Citations

This map shows the geographic impact of Hisafumi Okabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hisafumi Okabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hisafumi Okabe more than expected).

Fields of papers citing papers by Hisafumi Okabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hisafumi Okabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hisafumi Okabe. The network helps show where Hisafumi Okabe may publish in the future.

Co-authorship network of co-authors of Hisafumi Okabe

This figure shows the co-authorship network connecting the top 25 collaborators of Hisafumi Okabe. A scholar is included among the top collaborators of Hisafumi Okabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hisafumi Okabe. Hisafumi Okabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Huijsduijnen, Rob Hooft van, Somei Kojima, Dee Carter, et al.. (2020). Reassessing therapeutic antibodies for neglected and tropical diseases. PLoS neglected tropical diseases. 14(1). e0007860–e0007860. 20 indexed citations

Ishiguro, Takahiro, Yasuko Kinoshita, Masamichi Sugimoto, et al.. (2010). Abstract 2426: Anti-Glypican3 antibody for treatment of human liver cancer. Cancer Research. 70(8_Supplement). 2426–2426. 2 indexed citations

Yoshikubo, T, Yoshihiro Matsumoto, Masahiko Nanami, et al.. (2008). Humanized Sc(Fv)2 Minibody against C-Mpl Successfully Increased Platelet Number in Monkey and Increased Engraftment of Human Umbilical Cord Blood Cells in NOD/SCID Mouse.. Blood. 112(11). 2322–2322. 1 indexed citations

Kohchi, Yasunori, Kazuo Hattori, Nobuhiro Oikawa, et al.. (2007). Design and synthesis of novel prodrugs of 2′-deoxy-2′-methylidenecytidine activated by membrane dipeptidase overexpressed in tumor tissues. Bioorganic & Medicinal Chemistry Letters. 17(8). 2241–2245. 5 indexed citations

Yoshikubo, T, et al.. (2006). Differentiation and maintenance of mast cells from CD34+ human cord blood cells. Experimental Hematology. 34(3). 320–329. 7 indexed citations

Sagawa, M., Takatsune Shimizu, Naoshi Fukushima, et al.. (2006). A New Disulfide-Linked Dimer of a Single-Chain Antibody Fragment Against Human CD47 Induces Apoptosis in Lymphoid Malignant Cells In Vitro and In Vivo Via the HIF-1α Pathway: A Possible Novel Therapeutic Agent for B-CLL.. Blood. 108(11). 2097–2097.

Kimura, Naoki, Shigeto Kawai, Yasuko Kinoshita, et al.. (2004). 2D7 diabody bound to the α2 domain of HLA class I efficiently induces caspase-independent cell death against malignant and activated lymphoid cells. Biochemical and Biophysical Research Communications. 325(4). 1201–1209. 8 indexed citations

Suganuma, Kazuhiro, Tetsuro Kubota, Yoshiro Saikawa, et al.. (2003). Possible chemoresistance‐related genes for gastric cancer detected by cDNA microarray. Cancer Science. 94(4). 355–359. 52 indexed citations

Taniguchi, Mikio, Isao UMEDA, Kazuo Hattori, et al.. (2000). Synthesis and structure–activity relationships of novel fungal chitin synthase inhibitors. Bioorganic & Medicinal Chemistry Letters. 10(13). 1459–1462. 35 indexed citations

10.

Ishikawa, Yoshiki, Tetsuro Kubota, Masahiko Watanabe, et al.. (1999). Dihydropyrimidine dehydrogenase activity and messenger RNA level may be related to the antitumor effect of 5-fluorouracil on human tumor xenografts in nude mice.. PubMed. 5(4). 883–9. 106 indexed citations

11.

Sugano, Kokichi, Masaru Ishii, Hirofumi Koyama, et al.. (1994). [Clinical study of serum ErbB-2 protein using sandwich radioimmunometric assay (ErbB-2 IRMA 'Eiken')].. PubMed. 21(8). 1245–53. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact